Intellia Therapeutics (NTLA) Q2 2023 Earnings

3AugConfirmed
Nov 22
Q4 2022
Q1 2023
Q2 2023
-1.49
-1.38
-1.28
-1.17

Details

Expected EPS
-1.32
Actual EPS
-1.4
Surprise EPS
-0.08
Surprise Percent
+6.06%

Description

Intellia Therapeutics (NTLA) has reported earnings of -1.4 per share for Q2 2023.

0 Comments

Share your thoughts